Pictet Bank & Trust’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-35,140
Closed -$3.49M 66
2019
Q3
$3.49M Sell
35,140
-1,490
-4% -$142K 1.53% 19
2019
Q2
$3.39M Buy
36,630
+470
+1% +$44.6K 1.49% 19
2019
Q1
$3.41M Sell
36,160
-1,800
-5% -$157K 1.5% 20
2018
Q4
$2.43M Sell
37,960
-9,780
-20% -$722K 0.97% 29
2018
Q3
$4.27M Buy
47,740
+7,700
+19% +$680K 1.33% 22
2018
Q2
$3.18M Sell
40,040
-1,770
-4% -$147K 1.09% 23
2018
Q1
$3.73M Sell
41,810
-2,562
-6% -$246K 1.33% 21
2017
Q4
$4.63M Sell
44,372
-4,506
-9% -$508K 1.36% 19
2017
Q3
$7.13M Buy
48,878
+430
+0.9% +$58.6K 2.13% 14
2017
Q2
$6.29M Buy
48,448
+13,688
+39% +$1.68M 1.99% 14
2017
Q1
$4.33M Sell
34,760
-1,870
-5% -$224K 1.28% 19
2016
Q4
$4.24M Buy
36,630
+1,185
+3% +$132K 1.43% 20
2016
Q3
$3.71M Buy
35,445
+5,025
+17% +$544K 1.23% 28
2016
Q2
$3M Buy
30,420
+3,250
+12% +$336K 1.15% 27
2016
Q1
$2.72M Buy
+27,170
New +$2.8M 0.99% 29

Other funds holding CELG

Pictet Bank & Trust's CELG Position: Q4 2019 in Review

Pictet Bank & Trust sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 35,140 shares — an estimated $3.49M sold.

Pictet Bank & Trust first reported a position in CELG in Q1 2016 and held it in 15 quarters. The position peaked at $7.13M in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Pictet Bank & Trust reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Pictet Bank & Trust sold 35,140 Celgene Corp shares in Q4 2019, an estimated $3.49M.
  • Pictet Bank & Trust first reported a position in Celgene Corp in Q1 2016 and held it in 15 quarters.
  • Pictet Bank & Trust's Celgene Corp position peaked at $7.13M in Q3 2017.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Pictet Bank & Trust's 13F filing for Q4 2019, filed 31 Jan 2020.